Copper and ceruloplasmin status in serum of prostate and colon cancer patients.
Indian J Physiol Pharmacol
;
2003 Jan; 47(1): 108-10
Article
in English
| IMSEAR
| ID: sea-108927
ABSTRACT
Serum copper and ceruloplasmin levels were estimated in 20 patients each of prostate and colon cancer. Although copper to ceruloplasmin ratio was not significantly altered, copper and ceruloplasmin levels were increased significantly in the cancer patients as compared to controls. Trace elements and free radicals have been implicated in the etiology of cancer. Hence determination of specific antioxidants (like ceruloplasmin) and trace elements (like copper) may be of value in the early diagnosis of prostate and colon cancer.
Full text:
Available
Index:
IMSEAR (South-East Asia)
Main subject:
Prostatic Neoplasms
/
Humans
/
Male
/
Ceruloplasmin
/
Colonic Neoplasms
/
Statistics, Nonparametric
/
Copper
Type of study:
Screening study
Language:
English
Journal:
Indian J Physiol Pharmacol
Year:
2003
Type:
Article
Similar
MEDLINE
...
LILACS
LIS